Literature DB >> 18391077

Genotype-phenotype correlation in combined deficiency of factor V and factor VIII.

Bin Zhang1, Marta Spreafico, Chunlei Zheng, Angela Yang, Petra Platzer, Michael U Callaghan, Zekai Avci, Namik Ozbek, Johnny Mahlangu, Tabitha Haw, Randal J Kaufman, Kandice Marchant, Edward G D Tuddenham, Uri Seligsohn, Flora Peyvandi, David Ginsburg.   

Abstract

Combined deficiency of factor V and factor VIII (F5F8D) is caused by mutations in one of 2 genes, either LMAN1 or MCFD2. Here we report the identification of mutations for 11 additional F5F8D families, including 4 novel mutations, 2 in MCFD2 and 2 in LMAN1. We show that a novel MCFD2 missense mutation identified here (D81Y) and 2 previously reported mutations (D89A and D122V) abolish MCFD2 binding to LMAN1. Measurement of platelet factor V (FV) levels in 7 F5F8D patients (4 with LMAN1 and 3 with MCFD2 mutations) demonstrated similar reductions to those observed for plasma FV. Combining the current data together with all previous published reports, we performed a genotype-phenotype analysis comparing patients with MCFD2 mutations with those with LMAN1 mutations. A previously unappreciated difference is observed between these 2 classes of patients in the distribution of plasma levels for FV and factor VIII (FVIII). Although there is considerable overlap, the mean levels of plasma FV and FVIII in patients with MCFD2 mutations are significantly lower than the corresponding levels in patients with LMAN1 mutations. No differences in distribution of factor levels are observed by sex. These data suggest that MCFD2 may play a primary role in the export of FV and FVIII from the ER, with the impact of LMAN1 mediated indirectly through its interaction with MCFD2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391077      PMCID: PMC2424156          DOI: 10.1182/blood-2007-10-113951

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

1.  A rapid and simple ABO genotype screening method using a novel B/O2 versus A/O2 discriminating nucleotide substitution at the ABO locus.

Authors:  M L Olsson; M A Chester
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

2.  Combined factor V and factor VIII deficiency among non-Ashkenazi Jews.

Authors:  U Seligsohn; A Zivelin; E Zwang
Journal:  N Engl J Med       Date:  1982-11-04       Impact factor: 91.245

3.  Radioimmunoassay of factor V in human plasma and platelets.

Authors:  P B Tracy; L L Eide; E J Bowie; K G Mann
Journal:  Blood       Date:  1982-07       Impact factor: 22.113

Review 4.  Familial multiple coagulation factor deficiencies: new biologic insight from rare genetic bleeding disorders.

Authors:  B Zhang; D Ginsburg
Journal:  J Thromb Haemost       Date:  2004-09       Impact factor: 5.824

5.  The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis.

Authors:  Hongmin Sun; Tony L Yang; Angela Yang; Xixi Wang; David Ginsburg
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

6.  Isolation and study of an acquired inhibitor of human coagulation factor V.

Authors:  M E Nesheim; W L Nichols; T L Cole; J G Houston; R B Schenk; K G Mann; E J Bowie
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

7.  Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.

Authors:  J P Miletich; D W Majerus; P W Majerus
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

8.  A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.

Authors:  Lisa Gallinaro; Maria Grazia Cattini; Maryta Sztukowska; Roberto Padrini; Francesca Sartorello; Elena Pontara; Antonella Bertomoro; Viviana Daidone; Antonio Pagnan; Alessandra Casonato
Journal:  Blood       Date:  2008-02-01       Impact factor: 22.113

9.  Sustained correction of the bleeding time in an afibrinogenaemic patient after infusion of fresh frozen plasma.

Authors:  M Cattaneo; D Bettega; R Lombardi; A Lecchi; P M Mannucci
Journal:  Br J Haematol       Date:  1992-10       Impact factor: 6.998

10.  A mutation in LMAN1 (ERGIC-53) causing combined factor V and factor VIII deficiency is prevalent in Jews originating from the island of Djerba in Tunisia.

Authors:  Avichai Segal; Ariella Zivelin; Nurit Rosenberg; David Ginsburg; Ofer Shpilberg; Uri Seligsohn
Journal:  Blood Coagul Fibrinolysis       Date:  2004-01       Impact factor: 1.276

View more
  14 in total

1.  Crystallographic snapshots of the EF-hand protein MCFD2 complexed with the intracellular lectin ERGIC-53 involved in glycoprotein transport.

Authors:  Tadashi Satoh; Miho Nishio; Kousuke Suzuki; Maho Yagi-Utsumi; Yukiko Kamiya; Tsunehiro Mizushima; Koichi Kato
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-04-29       Impact factor: 1.056

2.  Analysis of MCFD2- and LMAN1-deficient mice demonstrates distinct functions in vivo.

Authors:  Min Zhu; Chunlei Zheng; Wei Wei; Lesley Everett; David Ginsburg; Bin Zhang
Journal:  Blood Adv       Date:  2018-05-08

3.  Genetics of intellectual disability in consanguineous families.

Authors:  Hao Hu; Kimia Kahrizi; Hans-Hilger Ropers; Hossein Najmabadi; Luciana Musante; Zohreh Fattahi; Ralf Herwig; Masoumeh Hosseini; Cornelia Oppitz; Seyedeh Sedigheh Abedini; Vanessa Suckow; Farzaneh Larti; Maryam Beheshtian; Bettina Lipkowitz; Tara Akhtarkhavari; Sepideh Mehvari; Sabine Otto; Marzieh Mohseni; Sanaz Arzhangi; Payman Jamali; Faezeh Mojahedi; Maryam Taghdiri; Elaheh Papari; Mohammad Javad Soltani Banavandi; Saeide Akbari; Seyed Hassan Tonekaboni; Hossein Dehghani; Mohammad Reza Ebrahimpour; Ingrid Bader; Behzad Davarnia; Monika Cohen; Hossein Khodaei; Beate Albrecht; Sarah Azimi; Birgit Zirn; Milad Bastami; Dagmar Wieczorek; Gholamreza Bahrami; Krystyna Keleman; Leila Nouri Vahid; Andreas Tzschach; Jutta Gärtner; Gabriele Gillessen-Kaesbach; Jamileh Rezazadeh Varaghchi; Bernd Timmermann; Fatemeh Pourfatemi; Aria Jankhah; Wei Chen; Pooneh Nikuei; Vera M Kalscheuer; Morteza Oladnabi; Thomas F Wienker
Journal:  Mol Psychiatry       Date:  2018-01-04       Impact factor: 15.992

4.  Molecular basis of LMAN1 in coordinating LMAN1-MCFD2 cargo receptor formation and ER-to-Golgi transport of FV/FVIII.

Authors:  Chunlei Zheng; Hui-Hui Liu; Shuguang Yuan; Jiahai Zhou; Bin Zhang
Journal:  Blood       Date:  2010-09-03       Impact factor: 22.113

5.  Structural basis for the cooperative interplay between the two causative gene products of combined factor V and factor VIII deficiency.

Authors:  Miho Nishio; Yukiko Kamiya; Tsunehiro Mizushima; Soichi Wakatsuki; Hiroaki Sasakawa; Kazuo Yamamoto; Susumu Uchiyama; Masanori Noda; Adam R McKay; Kiichi Fukui; Hans-Peter Hauri; Koichi Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

Review 6.  Combined deficiency of coagulation factors V and VIII: an update.

Authors:  Chunlei Zheng; Bin Zhang
Journal:  Semin Thromb Hemost       Date:  2013-07-12       Impact factor: 4.180

7.  Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin.

Authors:  Bin Zhang; Chunlei Zheng; Min Zhu; Jiayi Tao; Matthew P Vasievich; Andrea Baines; Jinoh Kim; Randy Schekman; Randal J Kaufman; David Ginsburg
Journal:  Blood       Date:  2011-07-27       Impact factor: 22.113

8.  EF-hand domains of MCFD2 mediate interactions with both LMAN1 and coagulation factor V or VIII.

Authors:  Chunlei Zheng; Hui-hui Liu; Jiahai Zhou; Bin Zhang
Journal:  Blood       Date:  2009-12-09       Impact factor: 22.113

Review 9.  Recent developments in the understanding of the combined deficiency of FV and FVIII.

Authors:  Bin Zhang
Journal:  Br J Haematol       Date:  2009-01-16       Impact factor: 6.998

10.  Successful percutaneous coronary intervention in a patient with combined deficiency of FV and FVIII due to novel compound heterozygous mutations in LMAN1.

Authors:  A J Patel; H-H Liu; R A Lager; V Malkovska; B Zhang
Journal:  Haemophilia       Date:  2013-04-05       Impact factor: 4.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.